Skip to main content
low economyUNVERIFIED

Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Only one outlet has reported this so far: treat it as unconfirmed.

📍 Hong Kong, HK·🕐 3d ago·1 outlet

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial public offering (IPO) in the city as soon as practicable, CEO Xian Jin said in an interview. “Biotech start-up fundraising in Hong Kong is never an easy game to play,” Jin said, adding that developing a...

How sure are we

1 outlet

Only one outlet so far: treat it as unconfirmed. That doesn’t make it false; it may be new, or an exclusive.

How we count · Check a link someone shared

Who reported it

Location
Verification Log

No verification data yet

Checks run automatically as new sources are ingested.

Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
82%

Very high · How we score this

Risk Score
low risk